185 related articles for article (PubMed ID: 17535880)
1. Estrogen receptor {beta}1 exerts antitumoral effects on SK-OV-3 ovarian cancer cells.
Treeck O; Pfeiler G; Mitter D; Lattrich C; Piendl G; Ortmann O
J Endocrinol; 2007 Jun; 193(3):421-33. PubMed ID: 17535880
[TBL] [Abstract][Full Text] [Related]
2. Effects of exon-deleted estrogen receptor beta transcript variants on growth, apoptosis and gene expression of human breast cancer cell lines.
Treeck O; Juhasz-Boess I; Lattrich C; Horn F; Goerse R; Ortmann O
Breast Cancer Res Treat; 2008 Aug; 110(3):507-20. PubMed ID: 17876701
[TBL] [Abstract][Full Text] [Related]
3. Novel estrogen receptor beta transcript variants identified in human breast cancer cells affect cell growth and apoptosis of COS-1 cells.
Treeck O; Pfeiler G; Horn F; Federhofer B; Houlihan H; Vollmer A; Ortmann O
Mol Cell Endocrinol; 2007 Jan; 264(1-2):50-60. PubMed ID: 17095148
[TBL] [Abstract][Full Text] [Related]
4. Detection of an elevated HER2 expression in MCF-7 breast cancer cells overexpressing estrogen receptor beta1.
Lattrich C; Juhasz-Boess I; Ortmann O; Treeck O
Oncol Rep; 2008 Mar; 19(3):811-7. PubMed ID: 18288420
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells.
Treeck O; Lattrich C; Springwald A; Ortmann O
Breast Cancer Res Treat; 2010 Apr; 120(3):557-65. PubMed ID: 19434490
[TBL] [Abstract][Full Text] [Related]
6. Inducible upregulation of oestrogen receptor-beta1 affects oestrogen and tamoxifen responsiveness in MCF7 human breast cancer cells.
Murphy LC; Peng B; Lewis A; Davie JR; Leygue E; Kemp A; Ung K; Vendetti M; Shiu R
J Mol Endocrinol; 2005 Apr; 34(2):553-66. PubMed ID: 15821116
[TBL] [Abstract][Full Text] [Related]
7. Involvement of estrogen receptor beta in ovarian carcinogenesis.
Bardin A; Hoffmann P; Boulle N; Katsaros D; Vignon F; Pujol P; Lazennec G
Cancer Res; 2004 Aug; 64(16):5861-9. PubMed ID: 15313930
[TBL] [Abstract][Full Text] [Related]
8. Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer.
Campbell-Thompson M; Lynch IJ; Bhardwaj B
Cancer Res; 2001 Jan; 61(2):632-40. PubMed ID: 11212261
[TBL] [Abstract][Full Text] [Related]
9. Loss of estrogen receptor beta isoform expression and its correlation with aberrant DNA methylation of the 5'-untranslated region in human epithelial ovarian carcinoma.
Suzuki F; Akahira J; Miura I; Suzuki T; Ito K; Hayashi S; Sasano H; Yaegashi N
Cancer Sci; 2008 Dec; 99(12):2365-72. PubMed ID: 19032364
[TBL] [Abstract][Full Text] [Related]
10. Glucocorticoids inhibit cell death in ovarian cancer and up-regulate caspase inhibitor cIAP2.
Runnebaum IB; Brüning A
Clin Cancer Res; 2005 Sep; 11(17):6325-32. PubMed ID: 16144937
[TBL] [Abstract][Full Text] [Related]
11. Detection and localization of an estrogen receptor beta splice variant protein (ERbeta2) in the adult female rat forebrain and midbrain regions.
Chung WC; Pak TR; Suzuki S; Pouliot WA; Andersen ME; Handa RJ
J Comp Neurol; 2007 Nov; 505(3):249-67. PubMed ID: 17879269
[TBL] [Abstract][Full Text] [Related]
12. A laminin-rich basement membrane matrix influences estrogen receptor beta expression and morphology of MDA-MB-231 breast cancer cells.
Neubauer H; Ruoff A; Paessler N; Solomayer E; Wallwiener D; Fehm T
Oncol Rep; 2009 Feb; 21(2):475-81. PubMed ID: 19148525
[TBL] [Abstract][Full Text] [Related]
13. Identification of wild type and variants of oestrogen receptors in polymorphonuclear and mononuclear leucocytes.
Stygar D; Westlund P; Eriksson H; Sahlin L
Clin Endocrinol (Oxf); 2006 Jan; 64(1):74-81. PubMed ID: 16402932
[TBL] [Abstract][Full Text] [Related]
14. Stable suppression of HER-2 gene expression using siRNA increases the lysis of human ovarian carcinoma cells mediated by NK-92 cell line.
Zhou Y; Cheng Z; Zhu H; Feng D; Zhao W; Ling B; Wei H; Tian Z
Oncol Rep; 2008 Dec; 20(6):1425-31. PubMed ID: 19020724
[TBL] [Abstract][Full Text] [Related]
15. [Effects of estrogen receptor beta on proliferation of ovarian clear cell adenocarcinoma ES-2 in vitro and in vivo].
Zhu J; Feng YJ
Zhonghua Fu Chan Ke Za Zhi; 2006 Sep; 41(9):588-91. PubMed ID: 17181966
[TBL] [Abstract][Full Text] [Related]
16. [Influence of estrogen and progestin on nm23-H1 expression in epithelial ovarian cancer cell lines via activation of phosphorylation signaling].
Hua KQ; Yao LQ; Cao Q; Huang Y; Zhao YQ; Feng YJ
Zhonghua Fu Chan Ke Za Zhi; 2006 Nov; 41(11):756-61. PubMed ID: 17327034
[TBL] [Abstract][Full Text] [Related]
17. MADD/DENN splice variant of the IG20 gene is necessary and sufficient for cancer cell survival.
Mulherkar N; Ramaswamy M; Mordi DC; Prabhakar BS
Oncogene; 2006 Oct; 25(47):6252-61. PubMed ID: 16682944
[TBL] [Abstract][Full Text] [Related]
18. Modulation of estrogen receptor-beta isoforms by phytoestrogens in breast cancer cells.
Cappelletti V; Miodini P; Di Fronzo G; Daidone MG
Int J Oncol; 2006 May; 28(5):1185-91. PubMed ID: 16596234
[TBL] [Abstract][Full Text] [Related]
19. Positive feedback activation of estrogen receptors by the CXCL12-CXCR4 pathway.
Sauvé K; Lepage J; Sanchez M; Heveker N; Tremblay A
Cancer Res; 2009 Jul; 69(14):5793-800. PubMed ID: 19584281
[TBL] [Abstract][Full Text] [Related]
20. Telomerase activity and p53-dependent apoptosis in ovarian cancer cells.
Akeshima R; Kigawa J; Takahashi M; Oishi T; Kanamori Y; Itamochi H; Shimada M; Kamazawa S; Sato S; Terakawa N
Br J Cancer; 2001 Jun; 84(11):1551-5. PubMed ID: 11384107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
